DURCAN DERMOT MARK 4

What Happened Dermot Durcan, a director of Cencora, was granted 905 restricted stock units (RSUs) on 2026-03-05. The grant is reported at $359.28 per share, totaling approximately $325,148. This was an award/grant (transaction code A) — an acquisition of compensation shares, not an open-market purchase.

Key Details

• Transaction date: 2026-03-05; Form 4 filed 2026-03-09 (timely filing within the two-business-day window).
• Grant: 905 RSUs at $359.28 per share; total reported value ≈ $325,148.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: RSUs were granted for no consideration and vest 100% on the first anniversary of the grant (vesting date ~2027-03-05).
• Transaction type: A = Award/Grant.

Context RSU grants are typically part of director or executive compensation and do not represent an immediate market purchase or sale. Because these units vest in one year, the shares are not transferable until they vest; this is standard compensation practice and should be interpreted as alignment via pay rather than a direct bullish market signal.